Skip Nav Destination
Issues
1 November 2010
-
Cover Image
Cover Image
The cover features a histology section from a patient's biopsy specimen of Barrett's esophagus stained with hemotoxylin and eosin (courtesy of Dr. Amitabh Srivastava, Dartmouth-Hitchcock Medical Center). The specimen features a region of dysplasia (upper left) next to a region of non-dysplasia, visually illustrating the concept of the phenotypic diversity that may be found within Barrett's esophagus. New work has provided a comprehensive analysis of measures of genetic diversity within a Barrett's esophagus segment as predictors of the risk for progression to esophageal adenocarcinoma. See articles by Merlo et al. (beginning on page 1388 ) and Michor and Polyak (beginning on page 1361 ) for more information. - PDF Icon PDF LinkTable of Contents
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Perspectives
Review
Research Articles
The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model
Altaf Mohammed; Naveena B. Janakiram; Qian Li; Venkateshwar Madka; Misty Ely; Stan Lightfoot; Howard Crawford; Vernon E. Steele; Chinthalapally V. Rao
Thiocolchicoside Exhibits Anticancer Effects through Downregulation of NF-κB Pathway and Its Regulated Gene Products Linked to Inflammation and Cancer
Simone Reuter; Sahdeo Prasad; Kanokkarn Phromnoi; Jayaraj Ravindran; Bokyung Sung; Vivek R. Yadav; Ramaswamy Kannappan; Madan M. Chaturvedi; Bharat B. Aggarwal
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.